Skip to Main Content

Paper Details

Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
PLoS One
5
2019
APOL1, APOL1 G1, APOL1 G1 and G2 variants, APOL1 gene, APOL1 genotype, APOL1 risk allele, APOL1 risk alleles, APOL1 risk variants, CSMD1, DPP6, HTN, Hypertension, Hypertensive, SNP rs286856, angiotensin receptor, candesartan, cardiovascular disease, kidney disease, risk allele, risk alleles, rs10113352, rs286856, thiazide, thiazides, while S
Author NameAffiliation
Megan L GroveSchool of Public Health, The University of Texas Health Science Center at Houston
Rhonda M Cooper-DeHoffDepartment of Pharmacotherapy and Translational Research, College of Medicine, University of Florida
Amber L BeitelsheesUniversity of Maryland
Julie A JohnsonDepartment of Pharmacotherapy and Translational Research, College of Medicine, University of Florida
Stephen T TurnerMayo Clinic
Eric BoerwinkleSchool of Public Health, The University of Texas Health Science Center at Houston
Eric BoerwinkleBaylor College of Medicine
Eric BoerwinkleSchool of Public Health, The University of Texas Health Science Center at Houston
Eric BoerwinkleBaylor College of Medicine
  • 1 - 9

Datasets

Release 1.2